RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 45.18

Change

+0.23 (+0.51)%

Market Cap

N/A

Volume

3.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.89 (+3.01%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le..

+23.68 (+3.69%)

USD 7.96B
QLD ProShares Ultra QQQ

+3.06 (+2.70%)

USD 7.84B
SSO ProShares Ultra S&P500

+2.02 (+2.12%)

USD 5.60B
UPRO ProShares UltraPro S&P500

+2.97 (+3.19%)

USD 4.27B
TECL Direxion Daily Technology Bull..

+2.90 (+2.97%)

USD 3.43B
YINN Direxion Daily FTSE China Bull..

+0.97 (+3.37%)

USD 1.61B
USD ProShares Ultra Semiconductors

+1.40 (+2.02%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+2.36 (+2.43%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

+0.18 (+0.19%)

USD 0.82B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.52 (+0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.26 (+0%)

USD 8.83B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.14% 30% F 34% F
Dividend Return 1.69% 76% C+ 29% F
Total Return 0.55% 30% F 27% F
Trailing 12 Months  
Capital Gain 0.27% 33% F 39% F
Dividend Return 1.72% 76% C+ 29% F
Total Return 1.99% 33% F 32% F
Trailing 5 Years  
Capital Gain 41.00% 67% D+ 70% C-
Dividend Return 4.06% 66% D+ 10% F
Total Return 45.06% 67% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 12.30% 28% F 70% C-
Dividend Return 12.57% 28% F 65% D
Total Return 0.27% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.34% 97% N/A 34% F
Risk Adjusted Return 40.11% 67% D+ 55% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.